Astex Pharmaceuticals

The mission of Astex Pharmaceuticals is to discover and develop novel therapeutics with a primary focus in cancer. The products we develop will be commercialized via partnerships with Otsuka subsidiaries worldwide.

CCO

Martin Buckland DPhil, MBA

President & Chief Corporate Officer

Martin Buckland was appointed President and Chief Corporate Officer of Astex Pharmaceuticals, Inc. in November 2020. He joined Astex Therapeutics Limited as Chief Business Officer in September 2004 and served as a member of the Board of Directors from July 2008 through the merger with SuperGen Inc. to create Astex Pharmaceuticals, Inc., in July 2011.

View Bio

EXPLORE

WEBSITE CAREERS NEWS

CONTACT

4420 Rosewood Drive
Suite 200
Pleasanton, CA 94588, USA

Tel: 1-925-560-0100

Fax: 1-925-560-0101